1. Home
  2. ACRS vs HITI Comparison

ACRS vs HITI Comparison

Compare ACRS & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$3.19

Market Cap

314.2M

Sector

Health Care

ML Signal

HOLD

Logo High Tide Inc.

HITI

High Tide Inc.

HOLD

Current Price

$2.32

Market Cap

257.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACRS
HITI
Founded
2012
2009
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
314.2M
257.8M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ACRS
HITI
Price
$3.19
$2.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$9.75
$6.13
AVG Volume (30 Days)
3.1M
507.2K
Earning Date
02-23-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,742,000.00
$423,857,911.00
Revenue This Year
N/A
$30.07
Revenue Next Year
N/A
$10.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.72
52 Week Low
$1.05
$1.64
52 Week High
$4.89
$4.06

Technical Indicators

Market Signals
Indicator
ACRS
HITI
Relative Strength Index (RSI) 48.13 41.22
Support Level $3.25 $2.24
Resistance Level $3.78 $2.50
Average True Range (ATR) 0.25 0.10
MACD -0.06 0.01
Stochastic Oscillator 13.52 41.86

Price Performance

Historical Comparison
ACRS
HITI

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.

Share on Social Networks: